Identification of a Prenyl Chalcone as a Competitive Lipoxygenase Inhibitor: Screening, Biochemical Evaluation and Molecular Modeling Studies

• Autor(a) principal: Zeraik, Maria Luiza [UNESP]
• Data de Publicação: 2021
• Outros Autores: Pauli, Ivani, Dutra, Luiz A. [UNESP], Cruz, Raquel S. [UNESP], Valli, Marilia [UNESP], Paracatu, Luana C. [UNESP], de Faria, Carolina M Q G [UNESP], Ximenes, Valdecir F. [UNESP], Regasini, Luis O. [UNESP], Andricopulo, Adriano D., Bolzani, Vanderlan S. [UNESP]
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.3390/molecules26082205; http://hdl.handle.net/11449/207682
• topic: chalcones; docking; inflammation; NuBBE database

Cyclooxygenase (COX) and lipoxygenase (LOX) are key targets for the development of new anti-inflammatory agents. LOX, which is involved in the biosynthesis of mediators in inflammation and allergic reactions, was selected for a biochemical screening campaign to identify LOX inhibitors by employing the main natural product library of Brazilian biodiversity. Two prenyl chalcones were identified as potent inhibitors of LOX-1 in the screening. The most active compound, (E)-2-O-farnesyl chalcone, decreased the rate of oxygen consumption to an extent similar to that of the positive control, nordihydroguaiaretic acid. Additionally, studies on the mechanism of the action indicated that (E)-2-O-farnesyl chalcone is a competitive LOX-1 inhibitor. Molecular modeling studies indicated the importance of the prenyl moieties for the binding of the inhibitors to the LOX binding site, which is related to their pharmacological properties.